Chronic Kidney Diseases Clinical Trials

139 recruiting

Chronic Kidney Diseases Trials at a Glance

139 actively recruiting trials for chronic kidney diseases are listed on ClinicalTrialsFinder across 6 cities in 41 countries. The largest study group is Not Applicable with 46 trials, with the heaviest enrollment activity in Boston, New York, and Beijing. Lead sponsors running chronic kidney diseases studies include Brigham and Women's Hospital, University of Colorado, Denver, and Charite University, Berlin, Germany.

Browse chronic kidney diseases trials by phase

Treatments under study

About Chronic Kidney Diseases Clinical Trials

Looking for clinical trials for Chronic Kidney Diseases? There are currently 139 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Chronic Kidney Diseases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Chronic Kidney Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 139 trials

Recruiting
Phase 2

Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus

Chronic Kidney DiseasesPruritus
Vifor Fresenius Medical Care Renal Pharma18 enrolled14 locationsNCT06593392
Recruiting
Phase 2

NAVIGATE Kidney: A Multi-level Intervention to Reduce Kidney Health Disparities

Chronic Kidney DiseasesKidney Diseases
University of Colorado, Denver448 enrolled2 locationsNCT06810622
Recruiting

Mixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Diabetes Mellitus

Chronic Kidney DiseasesDiabetes Mellitus, Type 2Diabetic Nephropathy Type 2 - Uncontrolled
Medical College of Wisconsin330 enrolled1 locationNCT05692388
Recruiting
Phase 3

Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial

SurgeryChronic Kidney DiseasesAcute Kidney Injury+1 more
Hamilton Health Sciences Corporation100 enrolled3 locationsNCT06337838
Recruiting

Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa

ObesityCardiovascular DiseasesChronic Kidney Diseases+8 more
Swiss Tropical & Public Health Institute1,200 enrolled1 locationNCT05881447
Recruiting
Early Phase 1

Concomitant Renal and Urinary Bladder Allograft Transplantation

Chronic Kidney DiseasesBladder DysfunctionNeurogenic Bladder+6 more
Mayo Clinic30 enrolled2 locationsNCT04626167
Recruiting
Phase 2

Ferric Citrate and Chronic Kidney Disease in Children

Chronic Kidney Diseases
University of California, Los Angeles160 enrolled20 locationsNCT04741646
Recruiting

Kidney Precision Medicine Project

Chronic Kidney DiseasesType 1 Diabetes (T1D)Kidney Failure, Acute+12 more
Icahn School of Medicine at Mount Sinai1,000 enrolled13 locationsNCT04334707
Recruiting
Not Applicable

SPYRAL GEMINI Pilot Study

Diabetes MellitusCardiovascular DiseasesHypertension+2 more
Medtronic Vascular175 enrolled13 locationsNCT06907147
Recruiting
Not Applicable

Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity

Chronic Kidney DiseasesMild Cognitive Impairment
Columbia University144 enrolled1 locationNCT05655325
Recruiting
Phase 1Phase 2

Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease

Heart FailureChronic Kidney DiseasesKidney Diseases+1 more
Northwestern University60 enrolled1 locationNCT05719714
Recruiting
Not Applicable

Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension

Diabetes MellitusCardiovascular DiseasesHypertension+2 more
Medtronic Vascular130 enrolled19 locationsNCT07115953
Recruiting

Chronic Kidney Disease-related Sarcopenia With Poor Prognosis

SarcopeniaChronic Kidney Diseases
Nanfang Hospital, Southern Medical University1,000 enrolled1 locationNCT05353660
Recruiting

Calciphylaxis in Patients With Chronic Kidney Disease - A Study of the Danish Calciphylaxis Research Initiative (DanCaRI)

Chronic Kidney DiseasesEnd Stage Renal Disease (ESRD)Calciphylaxis+2 more
Odense University Hospital860 enrolled1 locationNCT07511283
Recruiting

DYNAMic Renal Assessment: NOvel Methods to Assess KIDNEY Functional Reserve

Chronic Kidney Diseases
King's College Hospital NHS Trust44 enrolled1 locationNCT06572215
Recruiting
Phase 3

The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect

Chronic Kidney Diseases
The George Institute1,000 enrolled43 locationsNCT06058585
Recruiting
Phase 3

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Chronic Kidney DiseasesType 2 Diabetes Mellitus
Prokidney685 enrolled95 locationsNCT05099770
Recruiting

Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases

CancerMetabolic DiseaseChronic Kidney Diseases+3 more
University Hospital, Toulouse5,000 enrolled1 locationNCT05318196
Recruiting
Not Applicable

Home Hospital for Suddenly Ill Adults

Heart FailureAsthmaChronic Kidney Diseases+6 more
Brigham and Women's Hospital3,000 enrolled2 locationsNCT03524222
Recruiting

Histopathological Analysis of Renal Biopsies With Dynamic Full-field Optical Coherence Tomography, a Comparison to Conventional Histopathological Findings for the Diagnosis of Either Acute Kidney Injury or Chronic Kidney Disease in Routine Practices (NEPHROCT)

Chronic Kidney DiseasesAcute Kidney Injury
Centre Hospitalier William Morey - Chalon sur Saône50 enrolled1 locationNCT05728216